Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Hicks

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivoA Bond, N M Jones, C A Hicks, et al.
Neuroscience|September 24, 2004
Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatmentG De Foubert, S L Carney, C S Robinson, et al.
Brain Research|July 19, 2000
ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemiaM J O'Neill, T K Murray, D R McCarty, et al.
Brain Research|January 9, 2001
LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemiaM J O'Neill, C A Hicks, M A Ward, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivoA Bond, N M Jones, C A Hicks, et al.
Neuroscience|September 24, 2004
Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatmentG De Foubert, S L Carney, C S Robinson, et al.
Brain Research|July 19, 2000
ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemiaM J O'Neill, T K Murray, D R McCarty, et al.
Brain Research|January 9, 2001
LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemiaM J O'Neill, C A Hicks, M A Ward, et al.
Pageof 4